Doxycycline Does Not Cut Growth of Abdominal Aortic Aneurysms
Compared with placebo, no difference seen in growth of small abdominal aortic aneurysms at two years
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Workplace Wellness Programs Do Not Impact Clinical Outcomes
However, improvements seen in employees' health beliefs, number having a primary care physician
Delay in Treatment Seen for Acute Ischemic Stroke During COVID-19
Mean interval from last-known-well time to presentation significantly longer in March 2020
Significant Drop Seen in Type A Aortic Dissection After COVID-19
Monthly surgical case volume of aortic dissection declined 76.5 percent; volumes low in March, April
May 2020 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2020. This roundup includes the latest...
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
Prescribing reduced to just three prescriptions in the last week as new research highlights possible dangers
Globally, Women Less Likely to Develop Heart Disease Than Men
Rates of primary prevention higher in women, but secondary prevention efforts higher in men
